Announcements Trials
Browse Landscape

Phase

Phase 1 17Phase 2 10Phase 3 6Phase 1/2 2Phase NA 1Phase 2/3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 22NIH 15INDUSTRY 3NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Breast Neoplasms 9Central Nervous System Neoplasms 8Multiple Myeloma 7Lung Neoplasms 7Leukemia, Myeloid, Acute 6Ovarian Neoplasms 5Uterine Cervical Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Leukemia 4Gliosarcoma 4Glioblastoma 4Burkitt Lymphoma 4Squamous Cell Carcinoma of Head and Neck 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Congenital Abnormalities 3Colorectal Neoplasms 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Recurrence 2Radiation Injuries 2Pancreatic Neoplasms 2Osteosarcoma 2Oligodendroglioma 2Neuroblastoma 2Myelodysplastic Syndromes 2Lymphoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2

Interventions

veliparib 1transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1Temozolomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × NETWORK × Oligodendroglioma × Clear all
NCT01026493 2017-07-02

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

Radiation Therapy Oncology Group

Phase 1/2 Completed
257 enrolled 16 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

NCT00074334 2009-10-21

TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

Pediatric Brain Tumor Consortium

Phase 1/2 Terminated
3 enrolled
CNS

Familial ependymoma, Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡